News for 'Dr Reddy'

Kalpana Morparia addl director at Dr Reddys

Kalpana Morparia addl director at Dr Reddys

Rediff.com5 Jun 2007

Dr Reddys Laboratories announced on Tuesday that Kalpana Morparia has been appointed as an additional director on its board.

Dr Reddy's to form new drug firm

Dr Reddy's to form new drug firm

Rediff.com28 Sep 2005

Pharma major, Dr Reddy's Laboratories Ltd on Wednesday said it will form an integrated drug development company 'Perlecan Pharma Pvt Ltd' with an equity capital of $52.5 million from two venture capital investors.

Dr Reddy's teams up with NZ university

Dr Reddy's teams up with NZ university

Rediff.com8 Dec 2006

Dr Reddy's Laboratories has teamed up with the researchers at the University of Auckland to initiate global trials to test the capability of its new fixed dose combination (polypill) to prevent strokes and heart attacks

Dr Reddy's to sell 2 Merck generics

Dr Reddy's to sell 2 Merck generics

Rediff.com2 Feb 2006

But analysts see this as an encouraging shift of stance on part of Indian pharma companies that have so far been dependent on the patents challenge route.

Dr Reddy's gets USFDA nod for glimepiride

Dr Reddy's gets USFDA nod for glimepiride

Rediff.com10 Oct 2005

Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

Dr Reddy's opens biz school in Vietnam

Dr Reddy's opens biz school in Vietnam

Rediff.com27 Apr 2004

Dr Reddy's Foundation, the social arm of pharma major Dr Reddy's Laboratories, has set up its first Livelihood Advancement Business School centre outside India at Hanoi, Vietnam.

Dr Reddy's, Ranbaxy among best in Asia

Dr Reddy's, Ranbaxy among best in Asia

Rediff.com26 Mar 2003

Indian pharmaceutical majors Dr Reddy's Laboratories and Ranbaxy Labs have made it to the list of 105 best pharmaceutical companies in Asia.

Made in India Sputnik V to be available during Sept-Oct: Dr Reddy's

Made in India Sputnik V to be available during Sept-Oct: Dr Reddy's

Rediff.com27 Jul 2021

Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said.

How Dr Reddy's is rebranding itself

How Dr Reddy's is rebranding itself

Rediff.com6 Aug 2015

A new logo, colour and tagline were unveiled last month.

Dr Reddy's expands its US horizon

Dr Reddy's expands its US horizon

Rediff.com29 Nov 2010

Already having a deal with GlaxoSmithKline for marketing its products in various emerging markets, Dr Reddy's Laboratories had this week inked an agreement to buy the latter's oral penicillin manufacturing facility at Tennessee in the United States.

Dr Reddy's to form JV with Fujifilm Corporation

Dr Reddy's to form JV with Fujifilm Corporation

Rediff.com28 Jul 2011

Dr Reddy's Laboratories today said it will form a joint venture with Fujifilm Corporation to develop, manufacture and market generic drugs in Japan.

Dr Reddy's under scanner for packaging violations

Dr Reddy's under scanner for packaging violations

Rediff.com20 Aug 2014

In addition, the CPSC asserted that the company violated the CPSA by failing to immediately advise the CPSC of the alleged violations.

Dr Reddy's founder, chairman Anji Reddy is no more

Dr Reddy's founder, chairman Anji Reddy is no more

Rediff.com15 Mar 2013

Dr. K. Anji Reddy, Founder and Chairman of Dr. Reddy's Laboratories, died at a hospital in Hyderabad on Friday. He was 72.

New urology drug by Dr Reddy's

New urology drug by Dr Reddy's

Rediff.com3 Jul 2006

Dr Reddy's Laboratories Ltd has introduced a drug Alfuzosin Hydrochloride available in extended release tablets of 10 mg dosage.

Off-patents provide big opportunity: Dr Reddy

Off-patents provide big opportunity: Dr Reddy

Rediff.com10 Aug 2007

P B Jayakumar caught up Dr Reddy's chairman K Anji Reddy and tried to balance science and religion. And yes, there is also the question of choosing between the son and the son-in-law.

Dr Reddy's to sell Torrent drugs in Russia

Dr Reddy's to sell Torrent drugs in Russia

Rediff.com30 Nov 2006

Torrent Pharma, the pharmaceuticals major, has entered into a pact with Dr Reddy's Laboratories for exclusive commercialisation of two of its brands in Russia.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

Dr Reddy's files suit against Pfizer

Dr Reddy's files suit against Pfizer

Rediff.com24 Feb 2003

Dr Reddy's Laboratories Ltd filed a lawsuit seeking declaratory judgement against Pfizer in United States District Court for the District of New Jersey regarding its Abbreviated New Drug Application for Sertraline HCl.

Dr Reddy's to buy UCB's select brands for Rs 800 crore

Dr Reddy's to buy UCB's select brands for Rs 800 crore

Rediff.com1 Apr 2015

The transaction is expected to be closed in the first quarter of the financial year.

Dr Reddy's unveils Proscar in US

Dr Reddy's unveils Proscar in US

Rediff.com21 Jun 2006

Hyderabad-based Dr Reddy's Laboratory said on Wednesday it has launched the generic version of Merck & Co's prostate cancer drug Proscar in the US market after the expiry of its patent.

Dr Reddy's files for generic Allegra in US

Dr Reddy's files for generic Allegra in US

Rediff.com26 Mar 2003

Indian drugmaker Dr Reddy's Laboratories Ltd said on Wednesday it has filed with the US Food and Drug Administration to market a generic version of Aventis Pharmaceuticals' anti-allergy drug Allegra.

Dr Reddy's dilutes suit against Glaxo

Dr Reddy's dilutes suit against Glaxo

Rediff.com5 May 2004

In a bid to speed up the litigation process, the leading home-grown pharma company Dr Reddy's Laboratories has withdrawn its challenge against GlaxoSmithKline's "compound" patent for anti-nausea drug Zofran.

Novartis stops work on Dr Reddy's insulin drug

Novartis stops work on Dr Reddy's insulin drug

Rediff.com23 Jan 2003

Dr Reddy's Laboratories said on Thursday Novartis has decided to stop further work on an anti-diabetes compound licensed to the Swiss drug maker, the second time in six months that a foreign partner has halted development of the Indian firm's drugs.

Dr Reddy's launches generic Parkinson's disease tablets in US

Dr Reddy's launches generic Parkinson's disease tablets in US

Rediff.com7 Jun 2012

The tablets are bio equivalent generic version of GlaxoSmithKline's Requip XL tablets

Dr Reddy's bets big on drug discovery

Dr Reddy's bets big on drug discovery

Rediff.com23 Jul 2008

Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in Hyderabad on Tuesday.

Suspended MPs: 7 Rahul Loyalists, 1 Marxist

Suspended MPs: 7 Rahul Loyalists, 1 Marxist

Rediff.com3 Feb 2026

8 Member of Parliaments were suspended from Lok Sabha for tearing & throwing papers at the Chair till April 2. Uproar started when Rahul Gandhi was barred from citing former Army Chief, General M M Naravane's memoir on 2020 India-China clash. Rediff.com brings you the details of these MPs who were suspended.

Dr Reddy's A-team moves on putting house in order

Dr Reddy's A-team moves on putting house in order

Rediff.com10 Oct 2018

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.

Dr Reddy's launch generic version of Xyzal in US

Dr Reddy's launch generic version of Xyzal in US

Rediff.com28 Mar 2011

Hyderabad, Mar 28 (PTI) Dr Reddy's Laboratories Limited has launched Levocetirizine tablets (5mg), a bio-equivalent generic version of Xyzal tablets in the USA market, the company said on Monday.

Dr Reddy's may launch three new drugs in US

Dr Reddy's may launch three new drugs in US

Rediff.com9 Mar 2011

According to Dr Reddy's, the drugmaker may launch Rivastigmine, an anti-mild-to-moderate Alzheimer's drug, Desloratadine, used to treat allergies and Pseudoephedrine, a nasal/sinus decongestant.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

Dr Reddy's recalls Risperidone tablets in US

Dr Reddy's recalls Risperidone tablets in US

Rediff.com16 Apr 2010

Pharma major Dr Reddys Laboratories has voluntarily recalled 78,876 bottles of 2mg and 4mg Risperidone, generic version of Resperdal, tablets in the United States.

Dr Reddy's files second NDA in US

Dr Reddy's files second NDA in US

Rediff.com27 Jun 2003

US stops launch of Dr Reddy's drug

US stops launch of Dr Reddy's drug

Rediff.com14 Jun 2010

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis' anti-allergic drug, Allegra D24.

Dr Reddy's to set up two SEZs

Dr Reddy's to set up two SEZs

Rediff.com21 May 2007

Dr Reddy's Laboratories is setting up two special economic zones -- one each at Hyderabad and Visakhapatnam in Andhra Pradesh.

Dr Reddy's net profit up 7.4%, lags estimates

Dr Reddy's net profit up 7.4%, lags estimates

Rediff.com30 Jul 2013

The Hyderabad-based drugmaker said consolidated net profit rose to Rs Rs 361 crore (Rs 3.61 billion) for the fiscal first quarter ended June, from Rs 336 crore (Rs 3.36 billion) a year earlier.